Penn Capital Management Company LLC Makes New $535,000 Investment in Senseonics Holdings, Inc. Common Stock $SENS

Posted by Geri Gentry on Aug 30th, 2026

Penn Capital Management Company LLC purchased a new position in shares of Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS – Free Report) in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 94,140 shares of the company’s stock, valued at approximately $535,000. Penn Capital Management Company LLC owned approximately 0.23% of Senseonics Holdings, Inc. Common Stock as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other large investors also recently modified their holdings of the company. SPX Gestao de Recursos Ltda bought a new stake in Senseonics Holdings, Inc. Common Stock during the 2nd quarter worth $1,180,000. J.Safra Asset Management Corp bought a new position in Senseonics Holdings, Inc. Common Stock in the second quarter valued at about $636,000. Kestra Advisory Services LLC acquired a new stake in shares of Senseonics Holdings, Inc. Common Stock during the first quarter valued at about $68,000. GSK plc bought a new stake in shares of Senseonics Holdings, Inc. Common Stock during the fourth quarter worth about $60,000. Finally, The Manufacturers Life Insurance Company bought a new stake in shares of Senseonics Holdings, Inc. Common Stock during the second quarter worth about $65,000. 12.36% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

Several research analysts have recently issued reports on SENS shares. Weiss Ratings downgraded Senseonics Holdings, Inc. Common Stock from a “sell (d-)” rating to a “sell (e+)” rating in a research note on Wednesday, August 12th. Mizuho cut their target price on shares of Senseonics Holdings, Inc. Common Stock from $20.00 to $18.00 and set an “outperform” rating on the stock in a research report on Wednesday, July 15th. Wall Street Zen raised shares of Senseonics Holdings, Inc. Common Stock from a “strong sell” rating to a “sell” rating in a research note on Saturday, August 8th. Stifel Nicolaus cut their price target on shares of Senseonics Holdings, Inc. Common Stock from $9.00 to $8.00 and set a “hold” rating on the stock in a report on Monday, May 11th. Finally, HC Wainwright cut their price target on shares of Senseonics Holdings, Inc. Common Stock from $18.50 to $14.00 and set a “buy” rating on the stock in a report on Tuesday, May 12th. Four equities research analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, Senseonics Holdings, Inc. Common Stock has a consensus rating of “Moderate Buy” and an average target price of $17.20.

View Our Latest Analysis on SENS

Senseonics Holdings, Inc. Common Stock Stock Down 0.7%

SENS opened at $9.33 on Friday. Senseonics Holdings, Inc. Common Stock has a twelve month low of $4.79 and a twelve month high of $11.58. The business’s fifty day moving average price is $6.35. The firm has a market capitalization of $389.99 million, a PE ratio of -4.18 and a beta of 1.01. The company has a debt-to-equity ratio of 0.62, a quick ratio of 6.40 and a current ratio of 6.74.

Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS – Get Free Report) last issued its quarterly earnings results on Thursday, August 6th. The company reported ($0.63) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.55) by ($0.08). The business had revenue of $14.48 million for the quarter. Senseonics Holdings, Inc. Common Stock had a negative return on equity of 165.80% and a negative net margin of 225.09%. Sell-side analysts anticipate that Senseonics Holdings, Inc. Common Stock will post -2.29 EPS for the current fiscal year.

Insider Buying and Selling

In other Senseonics Holdings, Inc. Common Stock news, Director Douglas A. Roeder bought 13,953 shares of the stock in a transaction on Wednesday, August 19th. The stock was acquired at an average cost of $8.98 per share, for a total transaction of $125,297.94. Following the completion of the acquisition, the director owned 171,191 shares in the company, valued at $1,537,295.18. This trade represents a 8.87% increase in their position. The acquisition was disclosed in a document filed with the SEC, which is available at this link. 4.70% of the stock is owned by corporate insiders.

Senseonics Holdings, Inc. Common Stock Company Profile

(Free Report)

Senseonics Holdings, Inc develops and commercializes long-term implantable continuous glucose monitoring (CGM) systems for people with diabetes. The company’s primary product family is the Eversense system, which combines a small subcutaneously implanted sensor, a removable external transmitter, and companion smartphone applications to provide continuous glucose readings and alerts. Senseonics positions its technology as an alternative to wearable patch-style CGMs by offering multi-month sensor longevity and on-body vibration alerts delivered through the transmitter.

Senseonics supports clinical and commercial activities that include research and development, regulatory engagement, manufacturing and distribution, and training for healthcare providers who perform sensor insertion and removal.